Recent Developments across Biotechnology Sector

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts trends across biotechnology. Opiod addiction tests that have been approved, companies developing companion diagnostics kits, novel genetic tests, and potential drug-based treatments are illustrated through the most recent innovations. The corresponding clinical trial scenario for CAR T Cell is depicted along with industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered includ

Table of Contents

Recent Developments across Biotechnology SectorInnovations in Biotechnology Genetics SolutionsOpioid Addiction Drug with FDA Approval Likely to Be Available in Different Administration MethodsImmunotherapy Companies Developing Companion Diagnostic Services Drug Therapeutics to Improve Women’s Reproductive HealthGenetic Test Determines 70 Genetic Markers to Provide Personalized Skin Care SolutionsCAR T Cell Clinical Trials and Industry InteractionsClinical Trial Overview Involving Chimeric Antigen Receptors (CAR)-T Cells Worldwide (2007–2016)Industry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.